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Executive Summary 
This study was conducted to evaluate the potential of the chemical oxidation processes chlorine dioxide (ClO2) and 
ozone (O3) as tertiary treatment step to remove trace active pharmaceutical ingredients (APIs) in Swedish municipal 
wastewater treatment plants (WWTPs). Wastewater effluents of varying organic load (COD ~ 30-90 mg/L) were 
collected from different WWTPs in Sweden to represent different types of biological treatment. Batch experiments 
were carried out employing ClO2 (0-20 mg/L) and O3 (0-12 mg/L) to treat biologically treated wastewater spiked with 
approx. 1 µg/L mixed APIs. Additionally, treatment with peroxone (O3/H2O2) is carried out to enhance API oxidation 
rate by non-selective hydroxyl radicals. Some of the APIs investigated are shown in Fig. 1 and 2. From the ClO2 
treatment, API removal varied from no significant removal at the highest ClO2 dose to more than 90% removal with 
0.5 mg/L of the oxidant. The low COD effluent exhibited most of the APIs removed at 5 mg/L ClO2 dose while a 
significant increase in API removal from the high COD effluent after treatment with 8 mg/L ClO2.  
Shown in Fig. 1, treatment with ClO2  of low COD effluent removes diclofenac by >90% at low oxidant dose of 1.25 
mg/L while in high COD effluent around 3 mg/L ClO2 is needed to reach 90% removal. Repaglinide is also removed at 
low ClO2 dose. In comparison to ozonation, the same degree of removal of these APIs is reached but with much higher 
ozone dose. On the other hand, citalopram and trimetoprim in low COD effluent (Fig. 2) can be removed by ozonation 
at lower dose than ClO2. Ozonation significantly enhanced the removal of most APIs including carbamazepine, 
metoprolol, flutamid, bupropion and beclomethasone (Fig. 2). In addition, ozonation allows removal of ibuprofen in 
low COD wastewater but at higher oxidant dose. 
 
This study illustrates that treatment of wastewater containing trace pharmaceuticals is possible with either chlorine 
dioxide or ozone as additional treatment step depending on the target pollutant and taking into consideration the 
economic aspect of the process. For small-scale WWTPs, ClO2 treatment could be an option when ozonation is too 
expensive and complicated to operate. 
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Fig. 1. Comparison of API removal by ClO2 
in low (left bar graph) and high COD (right 
bar graph) effluents. 
Fig. 2. Comparison of API removal by O3 in 
low (left bar graph) and high COD (right bar 
graph) effluents. 
